Woodline Partners LP Adagio Therapeutics, Inc. Transaction History

Woodline Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.54 - $4.52 $505,363 - $899,308	198,962 New	198,962 $653,000
Q1 2022 May 16, 2022	SELL	$3.81 - $10.77 $381,000 - $1.08 Million	-100,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$6.35 - $47.04 $390,264 - $2.89 Million	-61,459 Reduced 38.06%	100,000 $726,000
Q3 2021 Nov 15, 2021	BUY	$20.88 - $56.08 $3.37 Million - $9.05 Million	161,459 New	161,459 $6.82 Million

63.9M

2.3K

2.1K

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.